Semaglutide is already being tested out in larger Phase III trials for the neurodegenerative condition.
Liraglutide and similar drugs mimic the hormone GLP-1, which helps regulate our blood sugar and appetite.
The trial involved 204 patients diagnosed with early Alzheimers, half of whom were given liraglutide.
A injection pen of Victoza (liraglutide) on top of pens of Wegovy (semaglutide)© Michael Siluk/UCG/Universal Images Group via Getty
Those on the drug also experienced an 18% slower decline in measured cognitive function during that time.
The teams findings were presented this week at the Alzheimers Association International Conference.
This research is preliminary; it hasnt yet gone through the peer-review process.
But the researchers do have several possible explanations.
News from the future, delivered to your present.
You May Also Like
Trump Is Promising to Lower Drug Prices.
Does Ozempic Really Cause Thyroid Cancer?
